Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial
about
Fibrinogen depleting agents for acute ischaemic strokeReperfusion therapies of acute ischemic stroke: potentials and failuresBeyond the time window of intravenous thrombolysis: standing by or by stenting?Advances in ischemic stroke treatment: neuroprotective and combination therapies.Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.Advances in medical revascularisation treatments in acute ischemic stroke.Adjunctive and alternative approaches to current reperfusion therapyCauses and consequences of critical bleeding and mechanisms of blood coagulation.Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.Past, present and future of alteplase for acute ischemic stroke.Microstructure and mechanics of collagen-fibrin matrices polymerized using ancrod snake venom enzymeProteome analysis of snake venom toxins: pharmacological insights.Hyperfibrinogenemia and functional outcome from acute ischemic strokePharmacotherapy of cerebral ischemia.Fibrin(ogen) and thrombotic disease.Intravenous tenecteplase in acute ischemic stroke: an updated review.The Virtual International Stroke Trials Archive (VISTA): results and impact on future stroke trials and management of stroke patients.Therapeutic Potential of Tenecteplase in the Management of Acute Ischemic Stroke.Changing Management of Acute Ischaemic Stroke: the New Treatments and Emerging Role of Endovascular Therapy.Snake venom toxins: toxicity and medicinal applications.Ancrod and fibrin formation: perspectives on mechanisms of action.Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke.Electroacupuncture improves neurovascular unit reconstruction by promoting collateral circulation and angiogenesis.Influence of red blood cell aggregation on perfusion of an artificial microvascular network.Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis.Co-overexpression of PpPDI enhances secretion of ancrod in Pichia pastoris.Defibrinogen Therapy for Acute Ischemic Stroke: 1332 Consecutive Cases.Tissue-type plasminogen activator as a therapeutic target in stroke
P2860
Q24201116-FC21E481-D57D-44B8-990A-461AB35EF09EQ26825758-82EB696D-CE0F-42B0-8479-12BB1E743A39Q30431536-F2AE39DD-2E9B-4112-A1F7-2A03550E1450Q33278117-6AB648A5-5791-44BF-AD61-C17EA32B8350Q34062853-E472A963-FA06-4D1F-87DB-E005866A3A70Q34459133-FA6BD519-0478-4D3F-8EE0-19D0A9A5E0D2Q35711810-2E58BDDC-7887-4229-B287-34B16D372746Q36920715-3B668BAC-1F2C-4CF4-9C81-028AE95FB2E6Q36925788-7508CA75-5C1E-46BE-B329-6594344DD12AQ37083630-A5392CD8-5E85-481C-B321-1C33EE024C51Q37332841-63AA02EE-3E3B-46B8-9A20-F599A61FF95AQ37352019-C569DB64-2062-4750-97BD-2DE65DD57A4CQ37414498-CA09B5D4-4275-4C6B-B021-D6B811EBA116Q37514167-6C229069-7A20-4A16-86C4-3ADAED87EF2AQ38117741-DFFCDBFA-3D05-4371-9D98-E7F3E529C22FQ38137688-A08A14BD-DFCF-45BE-843B-CB77D2C4E133Q38416663-FF4DC5C5-BAC4-4CDA-A57E-226D522CA2D9Q38589822-75822156-21AD-44D0-BD81-42D32CA4B408Q38790291-09645690-AE13-4605-99FE-F99128994F78Q38849314-89330A21-87E7-4F6A-BA1C-2E53F79E3EB2Q39760005-F4E7DA9D-224B-46CD-AC02-90D8D65F961DQ48558308-6B3B45B5-416A-4BBA-95A0-F016551252CCQ49368277-733DC920-93AA-45F9-A84A-D9F552B1D3A8Q50228503-600E7F58-0F2A-4292-A195-B3712285E162Q50877239-0968FE0B-5F33-42E0-A68D-CCC8B2EF40F2Q53080931-1DDEEC45-DF76-41CE-A16A-3658EAECD72EQ55395061-D2D176C2-8615-4053-993C-404F153F6620Q56336828-8596D647-0C88-45A4-B586-D348049DA0BC
P2860
Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Intravenous ancrod for acute i ...... a randomised controlled trial
@ast
Intravenous ancrod for acute i ...... a randomised controlled trial
@en
Intravenous ancrod for acute i ...... a randomised controlled trial
@nl
type
label
Intravenous ancrod for acute i ...... a randomised controlled trial
@ast
Intravenous ancrod for acute i ...... a randomised controlled trial
@en
Intravenous ancrod for acute i ...... a randomised controlled trial
@nl
prefLabel
Intravenous ancrod for acute i ...... a randomised controlled trial
@ast
Intravenous ancrod for acute i ...... a randomised controlled trial
@en
Intravenous ancrod for acute i ...... a randomised controlled trial
@nl
P2093
P1433
P1476
Intravenous ancrod for acute i ...... a randomised controlled trial
@en
P2093
Gian Luigi Lenzi
Jean Marc Orgogozo
Julien Bogousslavsky
Marc Verstraete
Michael G Hennerici
Richard Kay
P304
P356
10.1016/S0140-6736(06)69776-6
P407
P577
2006-11-25T00:00:00Z